These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 10728348)

  • 1. Cardiac fatty acid uptake and transport in health and disease.
    van der Vusse GJ; van Bilsen M; Glatz JF
    Cardiovasc Res; 2000 Jan; 45(2):279-93. PubMed ID: 10728348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of energy substrate metabolism in the diabetic heart.
    Stanley WC; Lopaschuk GD; McCormack JG
    Cardiovasc Res; 1997 Apr; 34(1):25-33. PubMed ID: 9217869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy.
    Zhang L; Jaswal JS; Ussher JR; Sankaralingam S; Wagg C; Zaugg M; Lopaschuk GD
    Circ Heart Fail; 2013 Sep; 6(5):1039-48. PubMed ID: 23861485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory networks controlling mitochondrial energy production in the developing, hypertrophied, and diabetic heart.
    Finck BN; Lehman JJ; Barger PM; Kelly DP
    Cold Spring Harb Symp Quant Biol; 2002; 67():371-82. PubMed ID: 12858562
    [No Abstract]   [Full Text] [Related]  

  • 5. Diabetic cardiomyopathy.
    Feuvray D
    Arch Mal Coeur Vaiss; 2004 Mar; 97(3):261-5. PubMed ID: 15106750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMPK signalling and the control of substrate use in the heart.
    Nagendran J; Waller TJ; Dyck JR
    Mol Cell Endocrinol; 2013 Feb; 366(2):180-93. PubMed ID: 22750050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty acid-binding proteins in the heart.
    Schaap FG; van der Vusse GJ; Glatz JF
    Mol Cell Biochem; 1998 Mar; 180(1-2):43-51. PubMed ID: 9546629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular mechanisms of the changes in myocardial energy metabolism in pathology].
    Saks VA; Smirnov VN
    Kardiologiia; 1980 May; 20(5):10-2. PubMed ID: 7392371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes.
    Kolwicz SC; Purohit S; Tian R
    Circ Res; 2013 Aug; 113(5):603-16. PubMed ID: 23948585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E receptor subtype 4 protects against diabetic cardiomyopathy by modulating cardiac fatty acid metabolism via FOXO1/CD36 signalling.
    Ying F; Liu H; Ching Tang EH; Lakhani I; Liu N; Xia Z; Liu S
    Biochem Biophys Res Commun; 2021 Apr; 548():196-203. PubMed ID: 33647796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic cardiomyopathies.
    Guertl B; Noehammer C; Hoefler G
    Int J Exp Pathol; 2000 Dec; 81(6):349-72. PubMed ID: 11298185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus.
    Finck BN; Lehman JJ; Leone TC; Welch MJ; Bennett MJ; Kovacs A; Han X; Gross RW; Kozak R; Lopaschuk GD; Kelly DP
    J Clin Invest; 2002 Jan; 109(1):121-30. PubMed ID: 11781357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic modification of the heart: transgenic modification of cardiac lipid and carbohydrate utilization.
    Hartil K; Charron MJ
    J Mol Cell Cardiol; 2005 Oct; 39(4):581-93. PubMed ID: 16140322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear receptor signaling and cardiac energetics.
    Huss JM; Kelly DP
    Circ Res; 2004 Sep; 95(6):568-78. PubMed ID: 15375023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy.
    Chiu HC; Kovacs A; Blanton RM; Han X; Courtois M; Weinheimer CJ; Yamada KA; Brunet S; Xu H; Nerbonne JM; Welch MJ; Fettig NM; Sharp TL; Sambandam N; Olson KM; Ory DS; Schaffer JE
    Circ Res; 2005 Feb; 96(2):225-33. PubMed ID: 15618539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role and regulation of CD36 for fatty acid imaging of the heart: implications in diabetes mellitus and chronic kidney disease.
    Aras O; Dilsizian V
    J Nucl Cardiol; 2007; 14(3 Suppl):S110-7. PubMed ID: 17556178
    [No Abstract]   [Full Text] [Related]  

  • 17. Modeling of palmitate transport in the heart.
    Bassingthwaighte JB; Noodleman L; van der Vusse G; Glatz JF
    Mol Cell Biochem; 1989 Jun 27-Jul 24; 88(1-2):51-8. PubMed ID: 2674667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of modern components of the mechanism of cardiac hypertrophy.
    Meerson FZ
    Circ Res; 1974 Aug; 35(2):suppl II:58-63. PubMed ID: 4276489
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulation of fatty acid oxidation in the mammalian heart in health and disease.
    Lopaschuk GD; Belke DD; Gamble J; Itoi T; Schönekess BO
    Biochim Biophys Acta; 1994 Aug; 1213(3):263-76. PubMed ID: 8049240
    [No Abstract]   [Full Text] [Related]  

  • 20. Heart fatty acid binding protein is a novel regulator of cardiac myocyte hypertrophy.
    Burton PB; Hogben CE; Joannou CL; Clark AG; Hsuan JJ; Totty NF; Sorensen C; Evans RW; Tynan MJ
    Biochem Biophys Res Commun; 1994 Dec; 205(3):1822-8. PubMed ID: 7811270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.